Unknown

Dataset Information

0

IL-11 is a crucial determinant of cardiovascular fibrosis.


ABSTRACT: Fibrosis is a common pathology in cardiovascular disease. In the heart, fibrosis causes mechanical and electrical dysfunction and in the kidney, it predicts the onset of renal failure. Transforming growth factor ?1 (TGF?1) is the principal pro-fibrotic factor, but its inhibition is associated with side effects due to its pleiotropic roles. We hypothesized that downstream effectors of TGF?1 in fibroblasts could be attractive therapeutic targets and lack upstream toxicity. Here we show, using integrated imaging-genomics analyses of primary human fibroblasts, that upregulation of interleukin-11 (IL-11) is the dominant transcriptional response to TGF?1 exposure and required for its pro-fibrotic effect. IL-11 and its receptor (IL11RA) are expressed specifically in fibroblasts, in which they drive non-canonical, ERK-dependent autocrine signalling that is required for fibrogenic protein synthesis. In mice, fibroblast-specific Il11 transgene expression or Il-11 injection causes heart and kidney fibrosis and organ failure, whereas genetic deletion of Il11ra1 protects against disease. Therefore, inhibition of IL-11 prevents fibroblast activation across organs and species in response to a range of important pro-fibrotic stimuli. These results reveal a central role of IL-11 in fibrosis and we propose that inhibition of IL-11 is a potential therapeutic strategy to treat fibrotic diseases.

SUBMITTER: Schafer S 

PROVIDER: S-EPMC5807082 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

IL-11 is a crucial determinant of cardiovascular fibrosis.

Schafer Sebastian S   Viswanathan Sivakumar S   Widjaja Anissa A AA   Lim Wei-Wen WW   Moreno-Moral Aida A   DeLaughter Daniel M DM   Ng Benjamin B   Patone Giannino G   Chow Kingsley K   Khin Ester E   Tan Jessie J   Chothani Sonia P SP   Ye Lei L   Rackham Owen J L OJL   Ko Nicole S J NSJ   Sahib Norliza E NE   Pua Chee Jian CJ   Zhen Nicole T G NTG   Xie Chen C   Wang Mao M   Maatz Henrike H   Lim Shiqi S   Saar Kathrin K   Blachut Susanne S   Petretto Enrico E   Schmidt Sabine S   Putoczki Tracy T   Guimarães-Camboa Nuno N   Wakimoto Hiroko H   van Heesch Sebastiaan S   Sigmundsson Kristmundur K   Lim See L SL   Soon Jia L JL   Chao Victor T T VTT   Chua Yeow L YL   Tan Teing E TE   Evans Sylvia M SM   Loh Yee J YJ   Jamal Muhammad H MH   Ong Kim K KK   Chua Kim C KC   Ong Boon-Hean BH   Chakaramakkil Mathew J MJ   Seidman Jonathan G JG   Seidman Christine E CE   Hubner Norbert N   Sin Kenny Y K KYK   Cook Stuart A SA  

Nature 20171113 7683


Fibrosis is a common pathology in cardiovascular disease. In the heart, fibrosis causes mechanical and electrical dysfunction and in the kidney, it predicts the onset of renal failure. Transforming growth factor β1 (TGFβ1) is the principal pro-fibrotic factor, but its inhibition is associated with side effects due to its pleiotropic roles. We hypothesized that downstream effectors of TGFβ1 in fibroblasts could be attractive therapeutic targets and lack upstream toxicity. Here we show, using inte  ...[more]

Similar Datasets

2017-12-11 | GSE107909 | GEO
| PRJNA421910 | ENA
2022-05-06 | GSE130983 | GEO
| S-EPMC9664718 | biostudies-literature
| S-EPMC2936124 | biostudies-literature
| S-EPMC9381906 | biostudies-literature
| S-EPMC3027139 | biostudies-literature
| S-EPMC6122968 | biostudies-literature
| S-EPMC7101157 | biostudies-literature
| S-EPMC5039681 | biostudies-literature